27 August 2021 in International Journal of Gynecology & Obstetrics
28 August 2020 in Journal of Endocrinological Investigation
1 December 2020 in Gene Reports
1 October 2021 in Turkish Journal of Biochemistry
Background: We aimed to clarify whether successful vitamin D supplementation could predict improved survival in breast cancer (BC) survivors after completion of adjuvant treatment. Materials and Methods: Patients were classified into four groups based on changes of 25(OH)D level during the treatment follow-up. Log-rank statistics were used to compare survival distributions among groups. ORs and 95% CIs were given for mortality ratios. Results: The risk of death in group II with low 25(OH)D levels was 4.2 times higher than in group I with high 25(OH)D levels. (OR = 4.17 (95% CI = 1.46–11.91), P = 0.008) and the risk of death in group IV whose 25(OH)D levels never increased was 4.3 times higher (OR = 4.29 (95% CI = 1.13–16.3)). According to the log-rank test, life expectancy was significantly higher in group II compared to group I (P = 0.017) and group III (P = 0.001). Group IV had significantly lower survival times than group III (P = 0.021). Conclusions: Vitamin D supplementation may play an important role in the response of the received treatments and provide a lower mortality rate and better overall -free survival (OFS) and disease-free survival (DFS) to BC patients. However, we observed a sign of poorer BC survival still after sufficient vitamin D supplementation.
26 April 2022 in Future Oncology
Aim: Vitamin D has a role in carcinogenesis and may have effect on recurrence. Thus, we aim to analyze the prognostic effect of vitamin D levels at beginning and follow-up together with the contrib...
31 March 2021 in Ege Tıp Dergisi
Aim: The purpose of this prospective cohort study is to evaluate the possible microbiome of the amniotic cavity in the second trimester in asymptomatic pregnant women by the culture-based technique. Materials and Methods: This prospective cohort study was conducted in Gaziantep University Gynecology and Obstetrics Clinic between October 2017 and November 2019. 100 pregnant women who had amniocentesis for genetic screening in the fetus, and who had no complaints or clinical symptoms of vaginal or chorioamnionitis infection, were included in the study. While culture tests were performed by using the amniotic fluids of these pregnant women, glucose and leukocyte levels of their amniotic fluids were also measured. At the same time, culture and gram staining analyses were performed by collecting vaginal swab specimens from the patients. Results: 12 patients (12%, 95% confidence interval, 0 to 41%) had positive amniotic fluid culture results. The most observed bacteria were E. coli (5%). No findings of clinical infection were observed in the patients with positive amniotic fluid culture results. These patients delivered healthy babies with no complications. Conclusion: The amniotic fluid has its own microbiome, and the vaginal flora plays a role in the formation of this microbiome. This is a preliminary study; therefore, larger studies and targeted broad range molecular methods are needed to find the variety of the possible flora of the amniotic fluid.